Cytovation

Round
cytovation.com Biotech & Healthcare Bergen, Norway
Total Funding $14M
Latest Round $6M Round
Last Announced Apr 23, 2025
Investors 2 Backers
Decision Makers 2 Available

About Cytovation

The power of immunotherapy can be directed at multiple diseases – from benign tumors to malignant cancers. CyPep-1 is a first-in-class tumor membrane targeted immunotherapy for the treatment of solid tumors.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Round
Global Headquarters Bergen, Norway
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website cytovation.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @cytovation (179 followers)
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $6,000,000 · Round

    fundraisingfox.com

  2. Capital Raise

    Raised $8,000,000 · Series-A

    fundraisingfox.com

Investors & Backers

2
Canica
Sandwater

Funding History

2 Rounds
Round equity · Apr 23, 2025
Series-A equity · Jun 2, 2023

Founders & Leadership

1

Lars Prestegarden

co-founder and Chief Executive Officer (CEO)

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts